Erasca, Inc. (ERAS)
13.61
-0.61
(-4.29%)
USD |
NASDAQ |
Nov 20, 16:00
13.74
+0.13
(+0.96%)
After-Hours: 20:00
Erasca Price to Book Value : 5.200 for Nov. 20, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2026 | 5.200 |
| November 19, 2026 | 5.433 |
| November 18, 2026 | 5.257 |
| November 17, 2026 | 5.307 |
| November 16, 2026 | 5.773 |
| November 13, 2026 | 5.983 |
| November 12, 2026 | 6.029 |
| November 11, 2026 | 6.418 |
| November 10, 2026 | 5.914 |
| November 09, 2026 | 5.964 |
| November 06, 2026 | 5.505 |
| November 05, 2026 | 5.070 |
| November 04, 2026 | 5.696 |
| November 03, 2026 | 5.593 |
| November 02, 2026 | 5.368 |
| October 30, 2026 | 5.482 |
| October 29, 2026 | 5.723 |
| October 28, 2026 | 5.777 |
| October 27, 2026 | 5.815 |
| October 26, 2026 | 5.727 |
| October 23, 2026 | 5.498 |
| October 22, 2026 | 5.364 |
| October 21, 2026 | 5.536 |
| October 20, 2026 | 5.586 |
| October 19, 2026 | 5.204 |
| Date | Value |
|---|---|
| October 16, 2026 | 5.116 |
| October 15, 2026 | 5.681 |
| October 14, 2026 | 5.616 |
| October 13, 2026 | 5.647 |
| October 12, 2026 | 5.906 |
| October 09, 2026 | 6.124 |
| October 08, 2026 | 5.906 |
| October 07, 2026 | 5.394 |
| October 06, 2026 | 5.463 |
| October 05, 2026 | 5.624 |
| October 02, 2026 | 5.631 |
| October 01, 2026 | 5.570 |
| September 30, 2026 | 5.601 |
| September 29, 2026 | 12.27 |
| September 28, 2026 | 12.20 |
| September 25, 2026 | 12.31 |
| September 24, 2026 | 12.54 |
| September 23, 2026 | 12.04 |
| September 22, 2026 | 13.43 |
| September 21, 2026 | 12.99 |
| September 18, 2026 | 12.76 |
| September 17, 2026 | 13.25 |
| September 16, 2026 | 13.27 |
| September 15, 2026 | 14.04 |
| September 14, 2026 | 13.96 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Twist Bioscience Corp. | 7.89 |
| Revolution Medicines, Inc. | 14.52 |
| Immunome, Inc. | 3.925 |
| Tango Therapeutics, Inc. | 3.751 |
| Oncolytics Biotech, Inc. | -- |
Price to Book Value Related Metrics
| PEG Ratio | -0.113 |
| Price | 13.61 |
| Earnings Yield | -7.32% |
| Market Cap | 4.767B |
| PEGY Ratio | -0.113 |